Loading provider…
Loading provider…
Hematology & Oncology Physician in Jacksonville, FL
NPI: 1376580696Primary Practice Location
BAPTIST HEALTH MEDICAL CENTER - JACKSONVILLE
800 Prudential Dr, Jacksonville, FL
Primary Employer
Tim's Home Medical of Brunswick, Inc
HQ Phone
Get D.O. Edward's Phone Numberphone_androidMobile
Get D.O. Edward's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License

FL State License
2015 - 2026

LA State License
2015 - 2016

PA State License
2005 - 2016

MD State License
1998 - 2000

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
UNE College of Osteopathic Medicine
une.edu
Medical School
Until 1995
Pennsylvania State University
Business
2012 - 2014
National Capital Consortium
Fellowship • Hematology and Medical Oncology
Until 2003
Tripler Army Medical Center
Residency • Internal Medicine
1995 - 1998
Internship • Internal Medicine
1995 - 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 34 | 53 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 28 | 29 |
Unusual warm autoimmune hemolytic anemia in non-alcoholic steatohepatitis.
Authors: William Difilippo
Journal: Ann Clin Lab Sci
Authors: Fernando Trespalacios
Journal: Hum Gene Ther
Authors: Youram Nassir, Stephen Noga, Alberto Bessudo, Ralph Boccia, James Berenson, Donald Gravenor, Robert Siegel, Dipti Patel-Donnelly
Journal: Br J Haematol
Publication Date: 2012-11-15
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Cyclophosphamide, DRUG: Ibrutinib, DRUG: Fludarabine Phosphate, BIOLOGICAL: Rituximab, OTHER: Pharmacogenomic Study
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, OTHER: Laboratory Biomarker Analysis, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Ibrutinib, BIOLOGICAL: Rituximab, PROCEDURE: Computed Tomography, PROCEDURE: Bone Marrow Aspiration, DRUG: Bendamustine Hydrochloride
Lead Sponsor: PrECOG, LLC.
Collaborators: Genentech, Inc.
Intervention / Treatment: BIOLOGICAL: Arm A: Rituximab, BIOLOGICAL: Arm B: GA101